Sun Pharma’s arm recalls 144 bottles of anti-depression drug from US market

20 Oct 2023 Evaluate

Sun Pharmaceutical Industries’ US-based subsidiary -- Sun Pharmaceutical Industries Inc has recalled 144 bottles of a generic anti-depression medicine from the US market due to a manufacturing issue. The company has initiated the recall for the affected lot of Bupropion Hydrochloride extended-release tablets due to failed dissolution specifications.  

The affected lot was manufactured at Sun Pharma's Halol-based plant in Gujarat and was distributed in the US by Sun Pharmaceutical Industries Inc, based in Princeton, New Jersy. Bupropion is a medication commonly used to treat depression. The US-based drug maker initiated the voluntary Class III nationwide (US) recall on October 4 this year.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1827.00 -10.30 (-0.56%)
09-Jan-2025 15:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1827.00
Dr. Reddys Lab 1373.60
Cipla 1491.70
Lupin 2250.40
Zydus Lifesciences 1008.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.